Precision Biosciences (DTIL) Liabilities from Discontinued Operations (2022 - 2025)

Precision Biosciences (DTIL) has 4 years of Liabilities from Discontinued Operations data on file, last reported at 885000.0 in Q3 2025.

• On a quarterly basis, Liabilities from Discontinued Operations fell 32.13% year-over-year to 885000.0 in Q3 2025; TTM through Sep 2025 was 885000.0, a 32.13% decrease from a year earlier, with the FY2024 full-year figure at 1204000.0, down 52.09% from the prior year.
• Liabilities from Discontinued Operations for Q3 2025 stood at 885000.0, roughly flat from 885000.0 in the prior quarter.
• Over the last five years, Liabilities from Discontinued Operations for DTIL reached as high as 2513000.0 in Q4 2023 and fell as low as 885000.0 in Q1 2025.
• Historically, Liabilities from Discontinued Operations has averaged 1384400.0 across 4 years, with a median of 1304000.0 in 2024.
• Across the five-year window, Liabilities from Discontinued Operations jumped 46.36% in 2023 and slumped 52.09% in 2024, its largest moves.
• Year by year, Liabilities from Discontinued Operations stood at 1717000.0 in 2022, then soared by 46.36% to 2513000.0 in 2023, then slumped by 52.09% to 1204000.0 in 2024, then fell by 26.5% to 885000.0 in 2025.
• Per Business Quant data, the three most recent Liabilities from Discontinued Operations figures were 885000.0 in Q3 2025, 885000.0 in Q2 2025, and 885000.0 in Q1 2025.